Title |
Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? a qualitative study
|
---|---|
Published in |
BMC Medical Informatics and Decision Making, July 2012
|
DOI | 10.1186/1472-6947-12-75 |
Pubmed ID | |
Authors |
Miriam J Johnson, Laura Sheard, Anthony Maraveyas, Simon Noble, Hayley Prout, Ian Watt, Dawn Dowding |
Abstract |
The treatment of cancer associated thrombosis (CAT) is well established, with level 1A evidence to support the recommendation of a low molecular weight heparin (LMWH) by daily injection for 3-6 months. However, registry data suggest compliance to clinical guidelines is poor. Clinicians face particular challenges in treating CAT in advanced cancer patients due to shorter life expectancy, increased bleeding risk and concerns that self injection may be too burdensome. For these reasons decision making around the diagnosis and management of CAT in people with advanced cancer, can be complex, and should focus on its likely net benefit for the patient. We explored factors that influence doctors' decision making in this situation and sought to gain an understanding of the barriers and facilitators to the application of best practice. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 2 | 67% |
United States | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
Unknown | 86 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 17% |
Student > Master | 14 | 16% |
Student > Bachelor | 10 | 11% |
Student > Ph. D. Student | 8 | 9% |
Student > Postgraduate | 8 | 9% |
Other | 16 | 18% |
Unknown | 16 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 36 | 41% |
Nursing and Health Professions | 13 | 15% |
Psychology | 6 | 7% |
Social Sciences | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 9 | 10% |
Unknown | 18 | 21% |